Long-term lung infections are a serious, ongoing threat to the lives of people with cystic fibrosis and take a significant toll on their physical and mental health. On August 25, 2020, CF research experts and members of the Infection Research Initiative Steering Committee came together to discuss the latest updates in infection research. Learn about current and upcoming research efforts to address key infection priorities, including nontuberculous mycobacteria (NTM), Aspergillus, and phage therapy.

1:54 | Infection Research Initiative Update with Dara Riva, M.S., Director of Clinical Research Awards
14:19 | Research Highlight: Nontuberculous mycobacteria (NTM) with Stacey Martiniano, MD, Children's Hospital of Colorado
25:40 | Research Highlight: Bacteriophage Therapy in CF with Jon Koff, MD, Yale University
39:07 | Research Highlight: Aspergillus in cystic fibrosis with Gina Hong, MD, University of Pennsylvania Perelman School of Medicine
51:55| Q&A

Learn more about the Infection Research Initiative: [ Ссылка ]

свернуть